T HERE have been a number of studies concerning the regulation of cortisol by the secretion of ACTH. 9, 17, 24, 25, 27 In the tuber cinereum in the ventral hypothalamus there seem to be structures which respond to the concentration of cortisol in the blood. These are able to produce an increase in ACTH secretion when the cortisol level is reduced, and a decrease when it rises. This feed-back mechanism is, however, only one of the factors which regulate the secretion of ACTH. Everything that, in the endocrinological sense, is usually summarized by the word "stress" increases ACTH secretion. Painful stimuli activate the hypothalamus by purely neural mechanisms via peripheral nerves and the spinal cord. hnmobilization stress activates the hypothalamus probably via the amygdala and stria terminalis. On the other hand, humoral substances liberated by tissue damage probably stimulate the hypophysial secretion of ACTH directly.
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In the central nervous system there are other mechanisms which inhibit the secretion of ACTH. The hippocampus-fornix system seems to be important in this connection and possibly also regulates the endogenous diurnal rhythm of cortisol production. It is now generally agreed that the link between the hypothalamus and the hypophysis is vascular and consists of the portal vessels. In the neurons of certain hypothalamic nuclei whose neurites connect with the first capillary network of the portal vessels in the median eminence, a substance, CRF (corticotrophin releasing factor), is produced. This is probably a polypeptide closely related to vasopressin. CRF is transported via the portal vessels to the ACTtt-producing cells in the anterior lobe of the hypophysis and contributes towards the production of ACTH.
The different links of this circuit provide a number of different possibilities for testing disturbances in the system, even in man. The Received for publication March 16, 1966. ACTH test for increasing the activity of the adrenal cortex is well-known. On the other hand, if a cortisol-like preparation (e.g. dexamethasone) is administered exogenously, the cortisol production is suppressed. No such response is obtained when a lesion is present somewhere in the system represented by the hypothalamus, hypophysis, and adrenal cortex, tIowever, this test is not suitable in hypo-function of the adrenal cortex. This is partly because the resultant suppression reduces the already low values, and analyses become difficult since low steroid concentrations cannot be determined with accuracy.
Liddle et al. TM suggested another method for studying the feed-back mechanism. By administering Metopirone | (methopyrapone, SU-4885) the final stage in the cortisol synthesis in the adrenal cortex is blocked. The blood cortisol level then decreases, causing a sthnulation of ACTH production and thereby an increase in steroid synthesis in the adrenal cortex up to the cortisol stage. If the feed-back mechanism is intact, a large increase in the urinary excretion of total 17hydroxycorticosteroids is observed. If any part of the chain is damaged, no such increase occurs. The Metopirone test has now become a routine endocrinological method.
This method has been used in cases of tumors of the hypophysis by several authors, 6,I~ where it has been shown that a pathological result is sometimes obtained, but usually the response is normal. Some findings 12' 13' 15 seem to indicate that the result obtained depends on the suprasellar distribution of the tumor. Other results have been confused by the fact that at the time of the test the patients had already undergone operation or roentgen therapy, or were taking anticonvulsive drugs. 22, 23 There has been no systematic investigation of sellar tumors, whose size may influence different structures in the hypothalamichypophysial region. Neither is it known whether the hypothalamus is also essential for 51,3 the cortisol-ACTH feed-back mechanism in man, and if so, which part of the hypothalamus is concerned.
The aim of our study was therefore to perform the Metopirone test on a large number of patients with tumors in the region of the sella tureiea (not only hypophysial) ; with the addition of other related data we could then attempt to establish the type, size and position of the tumor and its influence on certain surrounding structures. We were especially interested in purely suprasellar tumors such as meningiomas and subfrontal gliomas. We also hoped to obtain some idea of the practical uses of the test in neurology and neurosurgery. At the same time the Metopirone test was performed on a large number of normal cases and patients with organic neurological conditions of various kinds. These results will be reported elsewhereY a9 A preliminary report of our first 28 such cases was presented at a meeting of the Swedish Neurological Society in 1964. 2~
Material and Method
The original series drawn from the Neurological and Neurosurgical Clinics in Uppsala included 70 patients with tumors in the region of the sella tureiea. For different reasons, 22 of these patients were excluded from the series, some because of difficulty in demarcating the tumor anatomically, or because the Metopirone test was unsatisfactory. In other eases current medication with cortieoids or drugs acting on the central nervous system, such as anti-eonvulsants, phenothiazine derivatives or barbiturates, made the results difficult to evaluate, and these were also excluded from the series. A few of the patients were too ill or required immediate operation, and in these eases it was not possible to carry out the Metopirone test preoperatively.
Forty-eight patients thus remained and were used in the study; 40 of these were operated upon after the test. The diagnoses included chromophobe adenoma 27, meningioma 7, glioma 6, acromegaly 5, craniopharyngioma 2 and metastatic cancer 1. The anatomical extension of the tumors and their influence especially on the hypophysis, hypophysial stalk and hypothalamus were ascertained by inspection of the skull x-rays and air-encephalograms (in most cases with tomography) and by the operative reports on those patients who had undergone surgery.
The iV[etopirone test was performed preoperatively according to the method described by Liddle et alY The urine was collected for 1 to 3 days, during which period no medication was given, and and R. Hugosson 4.5 gin. Metopirone were then given by mouth in six 4-hourly doses. The urine was collected during this period and the following 24 hours. The urinary 17-ketosteroids (17-O) were determined according to Vestergaard's 2s modification of the Zimmcrmann and Callow procedure, and total 17-hydroxycorticosteroids (17-OH) according to the method of Birke et al. 1 The normal lower limit for 17-0H was placed at 7 mg. per 24 hours, according to values we obtained from a large standard series.
If the 17-0H values did not rise by at least 10 mg. during the 24 hours in which the Metopirone was given, or the following 25 hours, the test result was regarded as abnormal. The 17-O-steroid excretion is not greatly affected by Metopirone, and no definite conclusions could therefore be drawn from these determinations.
Results
The results of the Metopirone tests are given in Table 1 . On the basis of the test results, the cases have been divided into three groups, A, B, and C.
Group A. In 6 patients the initial 17-OH values were remarkably low (less than 5.1 mg./~4 hours) and there was no response to the Metopirone. Two of these patients had suprasellar meningiomas, and the other 4 had chromophobe adenomas, all verified surgically ( Fig. 1) .
Group B. In 17 cases some increase in the 17-OH excretion was observed, but the increase was less than 10 mg./~4 hours and was therefore regarded as abnormally low. However, the initial values lay above the lower normal limit (i.e. higher than 7 rag./24 hours) in no fewer than 10 of these cases. Eight of these 17 patients had chromophobe adenoma, 2 craniopharyngioma, 3 acromegaly, 3 suprasellar meningioma and 2 subfrontal glioma.
Group C. In 25 of the patients both the initial values and the response lay within the normal limits. Of these patients, ~ had suprasellar meningioma, 2 optic glioma, 2 thalamic glioma, 2 acromegaly, 1 metastatic cancer and 10 chromophobe adenoma. In addition this group included 6 patients with adenoma that had not been verified surgically (Fig. 2) .
It is evident from Table 1 that the site of the tumor is of great importance in the respouse to the Metopirone test. Groups A and B, which showed no response or abnormally low response, included all 8 patients in whom the tumor exerted pressure on the anterior part of the hypothalamus. In all except ~ of the 10 patients with purely intrasellar tumors, the test result was normal (Fig. 2) . The exceptions were one patient with acromegaly and one with a craniopharyngioma.
The significance of the location of the tumor becomes even more evident if we examine meningiomas and gliomas, which are primarily suprascllar tumors. Of the 7 patients with meningioma, 5 showed a pathological response to the Metopirone test ( Fig. 1 ). All of these 5 meningiomas exerted pressure on the anterior part of the hypothalamus. The other patients with meningioma showed normal results of the test. It is true that there was also some pressure on the hypothalamus in these cases but this was exerted more from the side, and from below, respectively. Among the 6 patients with glioma, had an optic glioma, in one of whom there was only slight pressure on the hypothalamus from below, and in the other only pressure on the hypophysis. Both patients showed a normal response to the Metopirone test. Two of the gliomas were subfrontal, with distinct pressure on the hypothalamus from the front, of the same type as in the meningiomas. In both of these cases the Metopirone test gave clearly pathological results. The 2 other gliomas were gliomas of the thalamus. There was no direct pressure on the anterior hypothalamus here, but only slight pressure from above. These two patients showed a very marked response to the ~r test (17-OH values rose to more than 50 mg./~4 hours), and we will return to this later.
With regard to the chromophobe adenomas, these were distributed among all three groups A, B and C. The adenomas in groups A and B, i.e. those with pathological response to the Metopirone test, were all fairly large, while all purelyintrasellar adenomas and those with very limited suprasellar extension were found in group C, i.e. those where the result of the Metopirone test was normal.
Discussion
It has been clearly shown in animal experiments 2 5,v,s,26 that the hypothalanms is essential for the cortisol-ACTH feed-back mechanism. This agrees well with our finding that Metopirone produced no response in tumors which exerted pressure on the anterior hypothalanms. Thus, in man, the anterior hypothalamus seems to be essential for this mechanism.
Obviously there will also be no response to Metopirone if the hypophysis is removed. It is well known, however, that the hypophysis has a large reserve capacity, and that a small residual amount of functioning hypophysial tissue is sufficient to prevent adrenocortieal insufficiency. A chromophobe adenoma probably always starts in a functioning hypophysis, but gradually increases and eomI)resses the remaining hypophysial tissue. A certain amount of functioning hypophysial tissue remains for a long period. Our results, showing that Metopirone only produces a pathological response with very large ehromophobe adenonms, appear to agree with this finding.
It is obvious that the feed-back mechanism requires a functioning relationship between the hypothalamus and the hypophysis, i.e. the portal vessels in the hypophysial stalk. However, [lie portal vessels Call adapt themselves to anatonfical changes. It is probably impossible to study the hypophysial stalk roentgenologieally, and even at operation it is difficult to deternfine whether the vessels are damaged or not. Our evaluations of tumorous influence on the hypophysial stalk should therefore be taken with reservation. It should be mentioned, however, that in all the patients with chromophobe adenomas in whom the Metopirone test gave a pathological result, the hypophysial stalk was believed to be affected by the tumor.
From a clinical point of view our most important conclusion appears to be that suprasellar meningiomas may cause severe adrenocortical insuIfieiency by destruction of the feed-back mechanism, apparently without any direct anatomical involvement of the hypophysis. This does not appear to have been made dear previously, and may be part of the explanation for the relatively high mortality rate after operations on suprasellar meningiomas. We believe that patients with this type of meningioma should be given eortisol substitution therapy both pre-and postoperatively.
As mentioned previously, in both eases of thalamic glioma a very pronounced response to Metopirone was observed (17-OH values of up to 85.5 Ing./~4 hours). It is known that ACTH production is influenced to some extent by the amygdala and hippoeampus via the stria terminMis and fornix, respeetivelyY Absence of suppressive mechanisms due to tunmrous destruction of these pathways may explain the very high values. This phenomenon may be compared to that of preeoeious puberty, which may also be caused by destruction of these same pathways.
The 5 acromegaly cases occupy a special position. The initial values of both 17-OH and 17-0 were completely nornml, but the response to Metopirone was very poor in 3 of the cases, in spite of the fact that the tunmr was small and exerted little pressure on the surrounding structures. Similar results were obtained by Gold et al) 2 and Kaplan) 4 None of the 5 patients with acromegaly studied by Gennes et al." responded to Metopirone. This can probably be explained by the fact that acromegaly is due to an excess production of certain hypophyseal hormones, in particular growth hormone, rather than by the relatively small degree of hypofunction that may be caused by the pressure of a tumor.
Summary
The Metopirone test was performed on 48 patients with tumors in the region of the sella turcica, as part of a preoperative endocrinologieal investigation. The anatomical relationship of the tumors to the hypothalamus, hypophysis and hypophysiM stalk was analysed with the aid of air-encephalographic, angiographic and operative findings.
Tumors which did not involve the hypophysis but which exerted pressure on the anterior hypothalamus (suprasellar meningiomas and subfrontal gliomas) gave pathological results with the Metopirone test. Small intrasellar tumors exerting only moderate pressure on the hypothalamus gave a normal result. Large adenomas generally gave pathological results.
The results indicate that the eortisol--ACTH feed-back mechanism in man as well as in animals functions via the hypothalamus. In man, a region in the anterior part of the hypothalamus seems to be important. From the clinical point of view the most important conclusion is that a purely suprasellar tumor such as a meningioma may cause a defect in adreno-cortical function.
